Abstract:

Objective　To analyze the clinical nursing value of Chinese medicine vapor-mist transdermal therapy for peripheral intravenous catheter (PIVC) phlebitis. Methods　A total of 102 patients with PIVC phlebitis treated in Henan Provincial Hospital of Traditional Chinese Medicine from January 2022 to December 2023 were selected as the study objects. The patients were divided into an experimental group (51 cases) and a control group (51 cases) by the random number table method. There were 27 males and 24 females in the experimental group, aged 18-60 (42.16±5.18) years, and the grade of phlebitis was grade Ⅲ in 40 cases and grade Ⅳ in 11 cases. There were 26 males and 25 females in the control group, aged 18-60 (42.03±5.11) years, and the grade of phlebitis was grade Ⅲ in 41 cases and grade Ⅳ in 10 cases. The control group took conventional traditional Chinese medicine topical treatment, and the experimental group took Chinese medicine vapor-mist transdermal therapy for 2 days. The treatment effect, vascular elasticity recovery status, pain degree before treatment and 2, 6, and 24 h after treatment [Numeric Rating Scale (NRS)], and inflammatory indexes before and after treatment [hypersensitive C-reactive protein (hs-CRP) and interleukin-6 (IL-6)] were compared between the two groups. Independent sample t test and χ² test were used for statistical analysis. Results　The total effective rate of the experimental group was higher than that of the control group [94.12% (48/51) vs. 80.39% (41/51)] (P<0.05). The normalization rate of vascular elasticity of the experimental group was higher than that of the control group [78.43% (40/51) vs. 47.06% (24/51)] (P<0.05). At 2 h, 6 h, and 24 h after treatment, the NRS scores of the experimental group were lower than those of the control group [(3.58±0.31) points vs. (4.36±0.39) points, (2.77±0.25) points vs. (3.92±0.33) points, (1.95±0.17) points vs. (2.84±0.24) points] (all P<0.05). After treatment, the levels of hs-CRP and IL-6 in the experimental group were lower than those in the control group [(8.73±0.72) mg/L vs. (13.05±1.18) mg/L, (3.93±0.32) μg/L vs. (7.58±0.67) μg/L] (both P<0.05). Conclusion　Chinese medicine vapor-mist transdermal therapy used in the clinical care of PIVC phlebitis can significantly improve the therapeutic effect, accelerate the recovery speed of vascular elasticity, relieve the pain of the body, and reduce the inflammatory response.

Key words:

Peripheral intravenous catheter, Phlebitis, Chinese medicine vapor-mist transdermal therapy, Conventional Chinese medicine external application

摘要：

目的　分析中药汽雾透皮疗法用于外周静脉留置针（PIVC）静脉炎的临床护理价值。方法　选取2022年1月至2023年12月河南省中医院收治的102例PIVC静脉炎患者作为研究对象。采用随机数字表法，将患者分为试验组（51例）和对照组（51例）。试验组男27例，女24例；年龄18～60（42.16±5.18）岁；静脉炎分级：Ⅲ级40例，Ⅳ级11例。对照组男26例，女25例；年龄18～60（42.03±5.11）岁；静脉炎分级：Ⅲ级41例，Ⅳ级10例。对照组采用常规中药外敷治疗，试验组采用中药汽雾透皮治疗。两组均连续治疗2 d。比较两组治疗效果、血管弹性恢复状况，治疗前和治疗后2 h、6 h、24 h疼痛程度［疼痛数字评分法（NRS）］，治疗前后炎症指标［超敏C反应蛋白（hs-CRP）、白细胞介素-6（IL-6）］。采用独立样本t检验和χ²检验进行统计学分析。结果　试验组治疗总有效率高于对照组［94.12%（48/51）比80.39%（41/51）］（P<0.05）；试验组血管弹性正常率高于对照组［78.43%（40/51）比47.06%（24/51）］（P<0.05）。治疗后2 h、6 h、24 h，试验组NRS评分均低于对照组［（3.58±0.31）分比（4.36±0.39）分、（2.77±0.25）分比（3.92±0.33）分、（1.95±0.17）分比（2.84±0.24）分］（均P<0.05）。治疗后，试验组hs-CRP、IL-6水平均低于对照组［（8.73±0.72）mg/L比（13.05±1.18）mg/L、（3.93±0.32）μg/L比（7.58±0.67）μg/L］（均P<0.05）。结论　中药汽雾透皮疗法可提高PIVC静脉炎患者治疗效果，加快血管弹性恢复速度，缓解机体疼痛，减轻炎症反应。

关键词:

外周静脉留置针, 静脉炎, 中药汽雾透皮疗法, 常规中药外敷